Pharmabiz1m
Univercells Technologies by Donaldson introduces scale-X nexo bioreactor for efficient cell culture process development across multiple modalities
Univercells Technologies by Donaldson introduces scale-X nexo bioreactor for efficient cell culture process development across multiple modalities: Nivelles, Belgium Saturday, Oct ...
Pharmabiz1h
UK government to fund research into wearable technology, virtual reality and AI to support to cut drug deaths
UK government to fund research into wearable technology, virtual reality and AI to support to cut drug deaths: United Kingdom Saturday, October 19, 2024, 13:00 Hrs [IST] The UK go ...
Pharmabiz1h
Krishna Eye Centre unveils Contoura Vision Laser machine to comprehensively treat all eye related problems under one roof
Our Bureau, Mumbai Saturday, October 19, 2024, 12:30 Hrs [IST] ...
Pharmabiz2h
AbbVie’s Vyalev receives US FDA approval to treat adults living with advanced Parkinson's disease
North Chicago, Illinois Saturday, October 19, 2024, 12:00 Hrs [IST] ...
Pharmabiz2h
Dharmesh Kharwar joins Entod Pharmaceuticals as independent director
Dharmesh Kharwar joins Entod Pharmaceuticals as independent director: Our Bureau, Mumbai Saturday, October 19, 2024, 11:30 Hrs [IST] Mumbai-based Entod Pharmaceuticals has appoint ...
Pharmabiz3h
MJFF launches initiative to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease
MJFF launches initiative to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease: New York Saturday, October 19, 2024, 11:00 Hrs [IST] The Mic ...
Pharmabiz4h
Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024
Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024: Rahway, New Jersey Saturday, October ...
Pharmabiz5h
EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer
EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Saturday, October 19, 202 ...
Pharmabiz6h
India needs multi-sectoral effort through govt to monitor elevated blood lead levels in young children: LM Singh
Nandita Vijayasimha, Bengaluru Saturday, October 19, 2024, 08:00 Hrs [IST] ...
Pharmabiz6h
Gujarat FDCA rolls out training for 150 officers on Revised Schedule M Guidelines
Gujarat FDCA rolls out training for 150 officers on Revised Schedule M Guidelines: Shardul Nautiyal, Mumbai Saturday, October ...
Pharmabiz6h
CARI advances studies on metabolic disorders via traditional and modern methodologies
CARI advances studies on metabolic disorders via traditional and modern methodologies: Nandita Vijayasimha, Bengaluru Saturday, October 19, 2024, 08:00 Hrs [IST] The Central Ayurv ...
Pharmabiz6h
IPA opens permanent office at Kalina, new office-bearers take charge of the association
IPA opens permanent office at Kalina, new office-bearers take charge of the association: Peethaambaran Kunnathoor, Chennai Saturday, October 19, 2024, 08:00 Hrs [IST] The Indian P ...